Terug
Dagbereik
€ 67,57
€ 69,28
52-Weeksbereik
€ 28,33
€ 84,94
Volume
1.484.761
50D / 200D Gem.
€ 72,52
/
€ 59,94
Vorige Slotkoers
€ 69,60
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -18,2 | 0,3 |
| P/B | — | 2,9 |
| ROE % | — | 3,7 |
| Net Margin % | -145,3 | 3,8 |
| Rev Growth 5Y % | 63,8 | 10,0 |
| D/E | — | 0,2 |
Koersdoel Analisten
Hold
€ 99,85
+45.7%
Low: € 83,00
High: € 157,00
Forward WPA
-€ 1,95
Omzet Sch.
920 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 8,89
€ 5,92 – € 10,87
|
4,1 B | 6 |
| FY2029 |
€ 6,64
€ 4,42 – € 8,12
|
3,3 B | 10 |
| FY2028 |
€ 3,70
€ 0,59 – € 6,05
|
2,4 B | 15 |
Belangrijkste Punten
Revenue grew 63,82% annually over 5 years — strong growth
Negative free cash flow of -447,01M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 62,44%
Capital efficient — spends only 0,22% of revenue on capex
Groei
Revenue Growth (5Y)
63,82%
Revenue (1Y)126,26%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
N/A
ROIC-65,45%
Net Margin-145,26%
Op. Margin-113,35%
Veiligheid
Debt / Equity
N/A
Current Ratio2,62
Interest Coverage-10,72
Waardering
P/E Ratio
-18,22
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 126,26% | Revenue Growth (3Y) | 634,64% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 63,82% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 502,08M | Net Income (TTM) | -729,31M |
| ROE | N/A | ROA | -77,92% |
| Gross Margin | 94,37% | Operating Margin | -113,35% |
| Net Margin | -145,26% | Free Cash Flow (TTM) | -447,01M |
| ROIC | -65,45% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2,62 |
| Interest Coverage | -10,72 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -18,22 | P/B Ratio | N/A |
| P/S Ratio | 26,46 | PEG Ratio | -0,65 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 13,29B | Enterprise Value | 15,44B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 502,08M | 221,90M | 9,30M | 77,65M | 69,72M |
| Net Income | -729,31M | -535,76M | -643,20M | -481,18M | -562,54M |
| EPS (Diluted) | -3,79 | -2,88 | -3,95 | -3,35 | -3,90 |
| Gross Profit | 473,81M | 218,02M | 6,86M | 74,21M | 66,60M |
| Operating Income | -569,09M | -592,97M | -607,37M | -512,20M | -576,63M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 936,03M | 919,34M | 546,38M | 623,04M | 1,01B |
| Total Liabilities | 3,01B | 2,38B | 1,89B | 1,87B | 1,88B |
| Shareholders' Equity | -2,08B | -1,47B | -1,35B | -1,25B | -870,41M |
| Total Debt | 2,73B | 1,73B | 1,74B | 1,72B | 1,73B |
| Cash & Equivalents | 570,12M | 681,10M | 375,94M | 376,69M | 393,77M |
| Current Assets | 753,68M | 720,69M | 477,59M | 548,85M | 888,86M |
| Current Liabilities | 287,97M | 154,40M | 143,84M | 121,43M | 135,07M |